MicroPort Endovascular Medtech Obtains Regulatory Approval for Detachable Fibered Embolic Coil

Stock News
03/13

Shanghai Microport Endovascular Medtech (Group) Co., Ltd. (688016.SH) has announced that its subsidiary, Shanghai Hongmai Medical Technology Co., Ltd., recently received a medical device registration certificate from the National Medical Products Administration for a detachable fibered embolic coil. The HawkMaster™/LongYuan™ detachable fibered embolic coil is the company's second coil embolization product approved for market launch, following the HawkNest™/YingChao™ fibered embolic coil. The introduction of this product further enriches the company's portfolio in the peripheral artery field and enhances its product offerings in the peripheral vascular interventional therapy sector.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10